Related Experiment Video
Updated: Jun 5, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer
Li Chen1, Yuan-Yuan Wu, Peigen Liu
1Department of Pathology, Nantong University School of Medicine, 226001 Nantong, China. bl1@ntu.edu.cn
Abstract:
To investigate the effect of down-regulation of VEGF (vascular endothelial growth factor) and HPV18 E6/E7 by hairpin RNA (shRNA) on cell proliferation, apoptosis, migration, invasion, and adhesion abilities of cervical carcinoma cells, recombinant plasmids including pS-E6 shRNA, pS-E7 shRNA, and pS-VEGF shRNA were constructed and transfected into HeLa cells. The levels of E6 mRNA, E7 mRNA, or VEGF mRNA were significantly reduced after transfection of pS-E6 shRNA (76.0%), pS-E7 shRNA (74.4%), and pS-VEGF shRNA (46.7%). VEGF expression was down-regulated by pS-E6 shRNA (55.1%) and pS-E7 shRNA (46.6%). The apoptosis of HeLa cells was increased, and the proliferation, invasion, and adhesion abilities were decreased significantly. For in vivo study, cancer cells that stably expressed the plasmids were cultured. Cells were transplanted subcutaneously into nude mice to establish xenograft tumor model. Finally, expression of E6 shRNA, E7 shRNA, and VEGF shRNA in cancer cells led to inhibition of the growth of xenograft. Hence, RNA interference could effectively suppress the expression of HPV18 E6/E7 and VEGF in human cervical cancer cells. This suppression attenuates malignant biological behavior of human cervical cancer cells. RNA interference of HPV E6/E7 or VEGF expression implies an effective anti-cervical cancer strategy.
Insights
RNA interference targeting human papillomavirus type 18 E6/E7 and vascular endothelial growth factor effectively suppresses cervical cancer cell growth and malignant behaviors. This RNA interference strategy shows promise for treating cervical cancer.
Area of Science:
- Oncology
- Molecular Biology
- Virology
Background:
- Cervical cancer is frequently associated with persistent infection by high-risk human papillomavirus (HPV), particularly HPV type 18.
- Vascular Endothelial Growth Factor (VEGF) plays a critical role in tumor angiogenesis and progression.
- HPV18 E6 and E7 oncoproteins are key drivers of cervical carcinogenesis.
Purpose of the Study:
- To investigate the therapeutic potential of down-regulating HPV18 E6/E7 and VEGF using RNA interference in cervical cancer cells.
- To assess the impact of this down-regulation on cancer cell proliferation, apoptosis, migration, invasion, and adhesion.
Main Methods:
- Construction and transfection of recombinant plasmids encoding short hairpin RNA (shRNA) targeting HPV18 E6, E7, and VEGF into HeLa cervical cancer cells.
- Evaluation of mRNA and protein expression levels post-transfection.
- Assessment of cellular proliferation, apoptosis, migration, invasion, and adhesion in vitro.
- Establishment of a xenograft tumor model in nude mice to evaluate in vivo efficacy.
Main Results:
- Transfection significantly reduced E6, E7, and VEGF mRNA levels, as well as VEGF protein expression.
- Down-regulation of HPV18 E6/E7 and VEGF increased apoptosis and decreased proliferation, invasion, and adhesion of HeLa cells.
- In vivo studies demonstrated significant inhibition of xenograft tumor growth.
Conclusions:
- RNA interference is an effective method to suppress HPV18 E6/E7 and VEGF expression in human cervical cancer cells.
- Suppression of these targets attenuates the malignant biological behavior of cervical cancer cells.
- Targeting HPV E6/E7 or VEGF expression via RNA interference represents a promising anti-cervical cancer strategy.
More Related Videos
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Related Concept Videos
Abnormal Proliferation
Mitogens and the Cell Cycle
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Negative Regulator Molecules
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...